With the current COVID-19 crisis imposing severe strains on the production and supply of key products in the medical, hygiene and protective equipment fields, a number of companies have pivoted their production facilities to help meet that shortfall.

You may have heard about Louis Vuitton repurposing its perfume production lines to make hand sanitiser in France, iPhone manufacturer Foxconn making surgical masks in China or car manufacturers making ventilators.

Unsurprisingly, there are a range of intellectual property implications for this change in production.

Read the full article here